Daily Stock Opinions and Ratings

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Opinions

Jim Cramer - Mad MoneyBausch & Lomb Inc.BOLBUYFeb 21, 2024

It just reported clean top and bottom line beats with good results across all three divisions. Management raised its full-year sales forecast.

Jim Cramer - Mad Money

Unknown

Unlock Rating

N/A

Stock price when the opinion was issued

biotechnologypharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

HOLD

Had a misstep on a contact lens solution and the stock dropped to the mid-$40's. He bought at that level, because even if all of their contact lens solution went to zero, they still had other businesses. Recent rumours have driven the stock up to $60.

DON'T BUY

Have been under investigation by the FCC. Also had some product defect.

DON'T BUY

Has never been a big fan of this company. Believes they had to restate some earnings which is what caused the stock price to dip.

TOP PICK

Has gone through a transition. Was suffering a few years ago when it lost its momentum, R&D lagged. Can see some growth opportunity in their new lens. New president has shaken down the company, cut costs and re-invigorated their R&D. Has exceeded expectations for 13 quarters.

Most Recent Experts